Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pieter C Smits

Showing results (81-90 of 186) with videos related to

Pageof 19
Sort By:
Journal of the American Heart Association|December 14, 2022
Utility of the ACC/AHA Lesion Classification to Predict Outcomes After Contemporary DES Treatment: Individual Patient Data Pooled Analysis From 7 Randomized TrialsMaayan Konigstein, Björn Redfors, Zixuan Zhang, et al.
European Heart Journal|January 8, 2005
The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery diseaseRon T van Domburg, Pedro A Lemos, Johanna J M Takkenberg, et al.
Journal of the American College of Cardiology|October 1, 2021
Assessing Microvascular Dysfunction in Angina With Unobstructed Coronary Arteries: JACC Review Topic of the WeekTijn P J Jansen, Regina E Konst, Suzette E Elias-Smale, et al.
Coronary Artery Disease|April 21, 2004
Effectiveness of the sirolimus-eluting stent in the treatment of patients with a prior history of coronary artery bypass graft surgeryAngela Hoye, Pedro A Lemos, Chourmouzios A Arampatzis, et al.
The Journal of Invasive Cardiology|May 21, 2004
Effectiveness of the sirolimus-eluting stent in the treatment of saphenous vein graft diseaseAngela Hoye, Pedro A Lemos, Chourmouzios A Arampatzis, et al.
Journal of the American College of Cardiology|June 13, 2015
Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-AnalysisTullio Palmerini, Umberto Benedetto, Giuseppe Biondi-Zoccai, et al.
Circulation|March 3, 2004
Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) studyPedro A Lemos, Angela Hoye, Dick Goedhart, et al.
Circulation|February 5, 2003
TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulationKengo Tanabe, Patrick W Serruys, Eberhard Grube, et al.
The American Journal of Cardiology|June 29, 2004
Effectiveness of sirolimus-Eluting stent implantation for coronary narrowings <50% in diameterAngela Hoye, Pedro A Lemos, Chourmouzios A Arampatzis, et al.
Journal of the American College of Cardiology|February 21, 2004
Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarctionPedro A Lemos, Francesco Saia, Sjoerd H Hofma, et al.
Pageof 19

Showing results (81-90 of 186) with videos related to

Sort By:
Pageof 19
Journal of the American Heart Association|December 14, 2022
Utility of the ACC/AHA Lesion Classification to Predict Outcomes After Contemporary DES Treatment: Individual Patient Data Pooled Analysis From 7 Randomized TrialsMaayan Konigstein, Björn Redfors, Zixuan Zhang, et al.
European Heart Journal|January 8, 2005
The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery diseaseRon T van Domburg, Pedro A Lemos, Johanna J M Takkenberg, et al.
Journal of the American College of Cardiology|October 1, 2021
Assessing Microvascular Dysfunction in Angina With Unobstructed Coronary Arteries: JACC Review Topic of the WeekTijn P J Jansen, Regina E Konst, Suzette E Elias-Smale, et al.
Coronary Artery Disease|April 21, 2004
Effectiveness of the sirolimus-eluting stent in the treatment of patients with a prior history of coronary artery bypass graft surgeryAngela Hoye, Pedro A Lemos, Chourmouzios A Arampatzis, et al.
The Journal of Invasive Cardiology|May 21, 2004
Effectiveness of the sirolimus-eluting stent in the treatment of saphenous vein graft diseaseAngela Hoye, Pedro A Lemos, Chourmouzios A Arampatzis, et al.
Journal of the American College of Cardiology|June 13, 2015
Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-AnalysisTullio Palmerini, Umberto Benedetto, Giuseppe Biondi-Zoccai, et al.
Circulation|March 3, 2004
Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) studyPedro A Lemos, Angela Hoye, Dick Goedhart, et al.
Circulation|February 5, 2003
TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulationKengo Tanabe, Patrick W Serruys, Eberhard Grube, et al.
The American Journal of Cardiology|June 29, 2004
Effectiveness of sirolimus-Eluting stent implantation for coronary narrowings <50% in diameterAngela Hoye, Pedro A Lemos, Chourmouzios A Arampatzis, et al.
Journal of the American College of Cardiology|February 21, 2004
Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarctionPedro A Lemos, Francesco Saia, Sjoerd H Hofma, et al.
Pageof 19